Gene: HDHD2
Official Full Name: haloacid dehalogenase like hydrolase domain containing 2provided by HGNC
Gene Summary: Enables enzyme binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25242 | HDHD2 Knockout cell line (HeLa) | Human | HDHD2 | 1:3~1:6 | Negative | Online Inquiry |
KO25243 | HDHD2 Knockout cell line (HCT 116) | Human | HDHD2 | 1:2~1:4 | Negative | Online Inquiry |
KO25244 | HDHD2 Knockout cell line (HEK293) | Human | HDHD2 | 1:3~1:6 | Negative | Online Inquiry |
KO25245 | HDHD2 Knockout cell line (A549) | Human | HDHD2 | 1:3~1:4 | Negative | Online Inquiry |
HDHD2 Gene Knockout Cell Lines are specialized cellular models engineered to disable the HDHD2 gene, which encodes an enzyme involved in lipid metabolism and cellular signaling. These cell lines serve as an invaluable resource for researchers interested in elucidating the biological functions of the HDHD2 gene, examining its role in various metabolic pathways, and understanding its implications in disease mechanisms, particularly in metabolic disorders and cancer.
The key function of HDHD2 Gene Knockout Cell Lines lies in their ability to mimic the physiological effects of gene loss, enabling scientists to study the resulting changes in cellular behavior and function. By disrupting the HDHD2 gene, these cell lines help delineate the contributions of this enzyme to cellular processes such as phospholipid homeostasis, signaling lipid regulation, and inflammation responses. The mechanisms underlying these alterations can be explored using various assays, thereby providing insights into novel therapeutic targets and biomarkers for disease.
The scientific importance of HDHD2 Knockout Cell Lines extends to both research and clinical applications, offering researchers tools to investigate metabolic pathways and screen potential drug compounds. The knowledge gained from studies utilizing these cell lines can lead to advancements in targeted therapies for conditions such as obesity, diabetes, and certain cancers, making them critical in translational research.
Compared to traditional wild-type cell lines, the HDHD2 Gene Knockout variants provide unique selling points, including the remarkable specificity of gene targeting, facilitating high-throughput screening processes and enabling detailed mechanistic studies. This specificity allows researchers to obtain clearer insights into gene function without the confounding effects of normal HDHD2 activity.
For researchers and clinicians, the value of HDHD2 Gene Knockout Cell Lines is profound; they offer an unprecedented opportunity to deepen our understanding of human health and disease mechanisms. With the ability to tailor experimental conditions and validate findings in a controlled environment, these models pave the way for innovative therapeutic strategies.
Our company specializes in providing high-quality biological products supported by extensive expertise in gene editing and cellular biology. We are committed to empowering researchers with the tools necessary to unravel the complexities of gene function and environmental interactions, and our HDHD2 Gene Knockout Cell Lines exemplify this dedication to advancing scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.